SEC Comment Letter for CASSAVA SCIENCES INC (FLNA) (CIK 0001069530) (FLNA) — Jan 26, 2010
CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)
Date: Jan. 26, 2010 · CIK: 0001069530 · Accession: 0000000000-10-004997
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-29959
Letter
Via Facsimile and U.S. Mail Mail Stop 4720 January 26, 2010 Peter S. Roddy Vice President and Chief Financial Officer Pain Therapeutics, Inc. 2211 Bridgepointe Parkway Suite 500 San Mateo, CA 944404 Re: Pain Therapeutics, Inc. Form 10-K for Fiscal Year Ended December 31, 2008 Filed February 13, 2009 Schedule 14A Filed April 06, 2009 File No. 000-29959 Dear Mr. Roddy:
We have completed our review of your Form 10-K and Schedule 14A and have no further comments at this time. S i n c e r e l y , J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f
Show Raw Text
Via Facsimile and U.S. Mail Mail Stop 4720 January 26, 2010 Peter S. Roddy Vice President and Chief Financial Officer Pain Therapeutics, Inc. 2211 Bridgepointe Parkway Suite 500 San Mateo, CA 944404 Re: Pain Therapeutics, Inc. Form 10-K for Fiscal Year Ended December 31, 2008 Filed February 13, 2009 Schedule 14A Filed April 06, 2009 File No. 000-29959 Dear Mr. Roddy: We have completed our review of your Form 10-K and Schedule 14A and have no further comments at this time. S i n c e r e l y , J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f